FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Cardinal Health Nuedexta Recall

Nuedexta (dextromethorphan HBr and quinidine sulfate) Capsules 20 mg/10 mg 60 capsules…

Cardinal Health Inc. · Dublin, OH

Risk level
Class II
Reported by FDA
Jun 2, 2021
Recall ID
D-0442-2021
Check your lot numberHow we source this data

Summary

Cardinal Health recalled Nuedexta starting Mar 15, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0442-2021 on Jun 2, 2021. Reason: CGMP Deviations: Intermittent exposure to temperature excursion during storage. Status: Terminated.

Why it was recalled

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Product description

Nuedexta (dextromethorphan HBr and quinidine sulfate) Capsules 20 mg/10 mg 60 capsules Rx only NDC 64597-301-60 Manufactured by Patheon, Inc. Whitby, ON L1N 5Z5, Canada

Lot numbers, UPCs & expiration codes

CFBFP

Where it was sold

FL, GA, SC

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0442-2021
Classification
Class II
Status
Terminated
Recall initiated
Mar 15, 2021
FDA report date
Jun 2, 2021
Quantity
255 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Cardinal Health Inc.

Original FDA data

Every field from FDA enforcement report D-0442-2021, exactly as published.

Show all FDA fields
City
Dublin
State
OH
Status
Terminated
Country
United States
Event ID
87512
Address
7000 Cardinal Pl
Code information
CFBFP
Postal code
43017-1091
Report date
Jun 2, 2021
Product type
Drugs
Recall number
D-0442-2021
Classification
Class II
Recalling firm
Cardinal Health Inc.
Product quantity
255 bottles
Termination date
Jun 17, 2024
Reason for recall
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Nuedexta (dextromethorphan HBr and quinidine sulfate) Capsules 20 mg/10 mg 60 capsules Rx only NDC 64597-301-60 Manufactured by Patheon, Inc. Whitby, ON L1N 5Z5, Canada
Distribution pattern
FL, GA, SC
Recall initiation date
Mar 15, 2021
Initial firm notification
Letter
Center classification date
May 24, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0442-2021, published Jun 2, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls